Dengue Vaccine Market Report

Global Dengue Vaccine Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Mar 10, 2022
  • PAGES：147
  • REPORT CODE：GMM807971
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Dengue Vaccine market report explains the definition, types, applications, major countries, and major players of the Dengue Vaccine market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Panacea Biotec

    • Sanofi

    • Medigen Biologics

    • Merck Sharp & Dohme

    • GlaxoSmithKline

    • Sun Pharmaceutical

    • Takeda Pharmaceuticals

    • GeneOne Life Sciences

    • US NIH

    • Vabiotec

    By Type:

    • CYD-TDV

    • DENVax or TAK-003

    • TetraVax-DV

    • TDENV PIV

    • V180

    • DNA vaccines

    By End-User:

    • Government institutions

    • Hospitals

    • NGOs

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Dengue Vaccine Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Dengue Vaccine Outlook to 2028- Original Forecasts

    • 2.2 Dengue Vaccine Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Dengue Vaccine Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Dengue Vaccine Market- Recent Developments

    • 6.1 Dengue Vaccine Market News and Developments

    • 6.2 Dengue Vaccine Market Deals Landscape

    7 Dengue Vaccine Raw Materials and Cost Structure Analysis

    • 7.1 Dengue Vaccine Key Raw Materials

    • 7.2 Dengue Vaccine Price Trend of Key Raw Materials

    • 7.3 Dengue Vaccine Key Suppliers of Raw Materials

    • 7.4 Dengue Vaccine Market Concentration Rate of Raw Materials

    • 7.5 Dengue Vaccine Cost Structure Analysis

      • 7.5.1 Dengue Vaccine Raw Materials Analysis

      • 7.5.2 Dengue Vaccine Labor Cost Analysis

      • 7.5.3 Dengue Vaccine Manufacturing Expenses Analysis

    8 Global Dengue Vaccine Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Dengue Vaccine Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Dengue Vaccine Export by Region (Top 10 Countries) (2017-2028)

    9 Global Dengue Vaccine Market Outlook by Types and Applications to 2022

    • 9.1 Global Dengue Vaccine Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global CYD-TDV Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global DENVax or TAK-003 Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global TetraVax-DV Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global TDENV PIV Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global V180 Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global DNA vaccines Consumption and Growth Rate (2017-2022)

    • 9.2 Global Dengue Vaccine Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Government institutions Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global NGOs Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Dengue Vaccine Market Analysis and Outlook till 2022

    • 10.1 Global Dengue Vaccine Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Dengue Vaccine Consumption (2017-2022)

      • 10.2.2 Canada Dengue Vaccine Consumption (2017-2022)

      • 10.2.3 Mexico Dengue Vaccine Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Dengue Vaccine Consumption (2017-2022)

      • 10.3.2 UK Dengue Vaccine Consumption (2017-2022)

      • 10.3.3 Spain Dengue Vaccine Consumption (2017-2022)

      • 10.3.4 Belgium Dengue Vaccine Consumption (2017-2022)

      • 10.3.5 France Dengue Vaccine Consumption (2017-2022)

      • 10.3.6 Italy Dengue Vaccine Consumption (2017-2022)

      • 10.3.7 Denmark Dengue Vaccine Consumption (2017-2022)

      • 10.3.8 Finland Dengue Vaccine Consumption (2017-2022)

      • 10.3.9 Norway Dengue Vaccine Consumption (2017-2022)

      • 10.3.10 Sweden Dengue Vaccine Consumption (2017-2022)

      • 10.3.11 Poland Dengue Vaccine Consumption (2017-2022)

      • 10.3.12 Russia Dengue Vaccine Consumption (2017-2022)

      • 10.3.13 Turkey Dengue Vaccine Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Dengue Vaccine Consumption (2017-2022)

      • 10.4.2 Japan Dengue Vaccine Consumption (2017-2022)

      • 10.4.3 India Dengue Vaccine Consumption (2017-2022)

      • 10.4.4 South Korea Dengue Vaccine Consumption (2017-2022)

      • 10.4.5 Pakistan Dengue Vaccine Consumption (2017-2022)

      • 10.4.6 Bangladesh Dengue Vaccine Consumption (2017-2022)

      • 10.4.7 Indonesia Dengue Vaccine Consumption (2017-2022)

      • 10.4.8 Thailand Dengue Vaccine Consumption (2017-2022)

      • 10.4.9 Singapore Dengue Vaccine Consumption (2017-2022)

      • 10.4.10 Malaysia Dengue Vaccine Consumption (2017-2022)

      • 10.4.11 Philippines Dengue Vaccine Consumption (2017-2022)

      • 10.4.12 Vietnam Dengue Vaccine Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Dengue Vaccine Consumption (2017-2022)

      • 10.5.2 Colombia Dengue Vaccine Consumption (2017-2022)

      • 10.5.3 Chile Dengue Vaccine Consumption (2017-2022)

      • 10.5.4 Argentina Dengue Vaccine Consumption (2017-2022)

      • 10.5.5 Venezuela Dengue Vaccine Consumption (2017-2022)

      • 10.5.6 Peru Dengue Vaccine Consumption (2017-2022)

      • 10.5.7 Puerto Rico Dengue Vaccine Consumption (2017-2022)

      • 10.5.8 Ecuador Dengue Vaccine Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Dengue Vaccine Consumption (2017-2022)

      • 10.6.2 Kuwait Dengue Vaccine Consumption (2017-2022)

      • 10.6.3 Oman Dengue Vaccine Consumption (2017-2022)

      • 10.6.4 Qatar Dengue Vaccine Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Dengue Vaccine Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Dengue Vaccine Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Dengue Vaccine Consumption (2017-2022)

      • 10.7.2 South Africa Dengue Vaccine Consumption (2017-2022)

      • 10.7.3 Egypt Dengue Vaccine Consumption (2017-2022)

      • 10.7.4 Algeria Dengue Vaccine Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Dengue Vaccine Consumption (2017-2022)

      • 10.8.2 New Zealand Dengue Vaccine Consumption (2017-2022)

    11 Global Dengue Vaccine Competitive Analysis

    • 11.1 Panacea Biotec

      • 11.1.1 Panacea Biotec Company Details

      • 11.1.2 Panacea Biotec Dengue Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Panacea Biotec Dengue Vaccine Main Business and Markets Served

      • 11.1.4 Panacea Biotec Dengue Vaccine Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Sanofi

      • 11.2.1 Sanofi Company Details

      • 11.2.2 Sanofi Dengue Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Sanofi Dengue Vaccine Main Business and Markets Served

      • 11.2.4 Sanofi Dengue Vaccine Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Medigen Biologics

      • 11.3.1 Medigen Biologics Company Details

      • 11.3.2 Medigen Biologics Dengue Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Medigen Biologics Dengue Vaccine Main Business and Markets Served

      • 11.3.4 Medigen Biologics Dengue Vaccine Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Merck Sharp & Dohme

      • 11.4.1 Merck Sharp & Dohme Company Details

      • 11.4.2 Merck Sharp & Dohme Dengue Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Merck Sharp & Dohme Dengue Vaccine Main Business and Markets Served

      • 11.4.4 Merck Sharp & Dohme Dengue Vaccine Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 GlaxoSmithKline

      • 11.5.1 GlaxoSmithKline Company Details

      • 11.5.2 GlaxoSmithKline Dengue Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 GlaxoSmithKline Dengue Vaccine Main Business and Markets Served

      • 11.5.4 GlaxoSmithKline Dengue Vaccine Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Sun Pharmaceutical

      • 11.6.1 Sun Pharmaceutical Company Details

      • 11.6.2 Sun Pharmaceutical Dengue Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Sun Pharmaceutical Dengue Vaccine Main Business and Markets Served

      • 11.6.4 Sun Pharmaceutical Dengue Vaccine Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Takeda Pharmaceuticals

      • 11.7.1 Takeda Pharmaceuticals Company Details

      • 11.7.2 Takeda Pharmaceuticals Dengue Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Takeda Pharmaceuticals Dengue Vaccine Main Business and Markets Served

      • 11.7.4 Takeda Pharmaceuticals Dengue Vaccine Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 GeneOne Life Sciences

      • 11.8.1 GeneOne Life Sciences Company Details

      • 11.8.2 GeneOne Life Sciences Dengue Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 GeneOne Life Sciences Dengue Vaccine Main Business and Markets Served

      • 11.8.4 GeneOne Life Sciences Dengue Vaccine Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 US NIH

      • 11.9.1 US NIH Company Details

      • 11.9.2 US NIH Dengue Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 US NIH Dengue Vaccine Main Business and Markets Served

      • 11.9.4 US NIH Dengue Vaccine Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Vabiotec

      • 11.10.1 Vabiotec Company Details

      • 11.10.2 Vabiotec Dengue Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Vabiotec Dengue Vaccine Main Business and Markets Served

      • 11.10.4 Vabiotec Dengue Vaccine Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    12 Global Dengue Vaccine Market Outlook by Types and Applications to 2028

    • 12.1 Global Dengue Vaccine Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global CYD-TDV Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global DENVax or TAK-003 Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global TetraVax-DV Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global TDENV PIV Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global V180 Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.6 Global DNA vaccines Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Dengue Vaccine Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Government institutions Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global NGOs Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Dengue Vaccine Market Analysis and Outlook to 2028

    • 13.1 Global Dengue Vaccine Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Dengue Vaccine Consumption Forecast (2022-2028)

      • 13.2.2 Canada Dengue Vaccine Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Dengue Vaccine Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Dengue Vaccine Consumption Forecast (2022-2028)

      • 13.3.2 UK Dengue Vaccine Consumption Forecast (2022-2028)

      • 13.3.3 Spain Dengue Vaccine Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Dengue Vaccine Consumption Forecast (2022-2028)

      • 13.3.5 France Dengue Vaccine Consumption Forecast (2022-2028)

      • 13.3.6 Italy Dengue Vaccine Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Dengue Vaccine Consumption Forecast (2022-2028)

      • 13.3.8 Finland Dengue Vaccine Consumption Forecast (2022-2028)

      • 13.3.9 Norway Dengue Vaccine Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Dengue Vaccine Consumption Forecast (2022-2028)

      • 13.3.11 Poland Dengue Vaccine Consumption Forecast (2022-2028)

      • 13.3.12 Russia Dengue Vaccine Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Dengue Vaccine Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Dengue Vaccine Consumption Forecast (2022-2028)

      • 13.4.2 Japan Dengue Vaccine Consumption Forecast (2022-2028)

      • 13.4.3 India Dengue Vaccine Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Dengue Vaccine Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Dengue Vaccine Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Dengue Vaccine Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Dengue Vaccine Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Dengue Vaccine Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Dengue Vaccine Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Dengue Vaccine Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Dengue Vaccine Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Dengue Vaccine Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Dengue Vaccine Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Dengue Vaccine Consumption Forecast (2022-2028)

      • 13.5.3 Chile Dengue Vaccine Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Dengue Vaccine Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Dengue Vaccine Consumption Forecast (2022-2028)

      • 13.5.6 Peru Dengue Vaccine Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Dengue Vaccine Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Dengue Vaccine Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Dengue Vaccine Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Dengue Vaccine Consumption Forecast (2022-2028)

      • 13.6.3 Oman Dengue Vaccine Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Dengue Vaccine Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Dengue Vaccine Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Dengue Vaccine Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Dengue Vaccine Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Dengue Vaccine Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Dengue Vaccine Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Dengue Vaccine Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Dengue Vaccine Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Dengue Vaccine Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Dengue Vaccine

    • Figure of Dengue Vaccine Picture

    • Table Global Dengue Vaccine Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Dengue Vaccine Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global CYD-TDV Consumption and Growth Rate (2017-2022)

    • Figure Global DENVax or TAK-003 Consumption and Growth Rate (2017-2022)

    • Figure Global TetraVax-DV Consumption and Growth Rate (2017-2022)

    • Figure Global TDENV PIV Consumption and Growth Rate (2017-2022)

    • Figure Global V180 Consumption and Growth Rate (2017-2022)

    • Figure Global DNA vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Government institutions Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global NGOs Consumption and Growth Rate (2017-2022)

    • Figure Global Dengue Vaccine Consumption by Country (2017-2022)

    • Table North America Dengue Vaccine Consumption by Country (2017-2022)

    • Figure United States Dengue Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Canada Dengue Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Mexico Dengue Vaccine Consumption and Growth Rate (2017-2022)

    • Table Europe Dengue Vaccine Consumption by Country (2017-2022)

    • Figure Germany Dengue Vaccine Consumption and Growth Rate (2017-2022)

    • Figure UK Dengue Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Spain Dengue Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Belgium Dengue Vaccine Consumption and Growth Rate (2017-2022)

    • Figure France Dengue Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Italy Dengue Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Denmark Dengue Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Finland Dengue Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Norway Dengue Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Sweden Dengue Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Poland Dengue Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Russia Dengue Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Turkey Dengue Vaccine Consumption and Growth Rate (2017-2022)

    • Table APAC Dengue Vaccine Consumption by Country (2017-2022)

    • Figure China Dengue Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Japan Dengue Vaccine Consumption and Growth Rate (2017-2022)

    • Figure India Dengue Vaccine Consumption and Growth Rate (2017-2022)

    • Figure South Korea Dengue Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Dengue Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Dengue Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Dengue Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Thailand Dengue Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Singapore Dengue Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Dengue Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Philippines Dengue Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Dengue Vaccine Consumption and Growth Rate (2017-2022)

    • Table South America Dengue Vaccine Consumption by Country (2017-2022)

    • Figure Brazil Dengue Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Colombia Dengue Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Chile Dengue Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Argentina Dengue Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Dengue Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Peru Dengue Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Dengue Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Dengue Vaccine Consumption and Growth Rate (2017-2022)

    • Table GCC Dengue Vaccine Consumption by Country (2017-2022)

    • Figure Bahrain Dengue Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Dengue Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Oman Dengue Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Qatar Dengue Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Dengue Vaccine Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Dengue Vaccine Consumption and Growth Rate (2017-2022)

    • Table Africa Dengue Vaccine Consumption by Country (2017-2022)

    • Figure Nigeria Dengue Vaccine Consumption and Growth Rate (2017-2022)

    • Figure South Africa Dengue Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Egypt Dengue Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Algeria Dengue Vaccine Consumption and Growth Rate (2017-2022)

    • Table Oceania Dengue Vaccine Consumption by Country (2017-2022)

    • Figure Australia Dengue Vaccine Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Dengue Vaccine Consumption and Growth Rate (2017-2022)

    • Table Panacea Biotec Company Details

    • Table Panacea Biotec Dengue Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Panacea Biotec Dengue Vaccine Main Business and Markets Served

    • Table Panacea Biotec Dengue Vaccine Product Portfolio

    • Table Sanofi Company Details

    • Table Sanofi Dengue Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Dengue Vaccine Main Business and Markets Served

    • Table Sanofi Dengue Vaccine Product Portfolio

    • Table Medigen Biologics Company Details

    • Table Medigen Biologics Dengue Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Medigen Biologics Dengue Vaccine Main Business and Markets Served

    • Table Medigen Biologics Dengue Vaccine Product Portfolio

    • Table Merck Sharp & Dohme Company Details

    • Table Merck Sharp & Dohme Dengue Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Sharp & Dohme Dengue Vaccine Main Business and Markets Served

    • Table Merck Sharp & Dohme Dengue Vaccine Product Portfolio

    • Table GlaxoSmithKline Company Details

    • Table GlaxoSmithKline Dengue Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Dengue Vaccine Main Business and Markets Served

    • Table GlaxoSmithKline Dengue Vaccine Product Portfolio

    • Table Sun Pharmaceutical Company Details

    • Table Sun Pharmaceutical Dengue Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sun Pharmaceutical Dengue Vaccine Main Business and Markets Served

    • Table Sun Pharmaceutical Dengue Vaccine Product Portfolio

    • Table Takeda Pharmaceuticals Company Details

    • Table Takeda Pharmaceuticals Dengue Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Takeda Pharmaceuticals Dengue Vaccine Main Business and Markets Served

    • Table Takeda Pharmaceuticals Dengue Vaccine Product Portfolio

    • Table GeneOne Life Sciences Company Details

    • Table GeneOne Life Sciences Dengue Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table GeneOne Life Sciences Dengue Vaccine Main Business and Markets Served

    • Table GeneOne Life Sciences Dengue Vaccine Product Portfolio

    • Table US NIH Company Details

    • Table US NIH Dengue Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table US NIH Dengue Vaccine Main Business and Markets Served

    • Table US NIH Dengue Vaccine Product Portfolio

    • Table Vabiotec Company Details

    • Table Vabiotec Dengue Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Vabiotec Dengue Vaccine Main Business and Markets Served

    • Table Vabiotec Dengue Vaccine Product Portfolio

    • Figure Global CYD-TDV Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global DENVax or TAK-003 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global TetraVax-DV Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global TDENV PIV Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global V180 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global DNA vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Government institutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global NGOs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Dengue Vaccine Consumption Forecast by Country (2022-2028)

    • Table North America Dengue Vaccine Consumption Forecast by Country (2022-2028)

    • Figure United States Dengue Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Dengue Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Dengue Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Dengue Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Germany Dengue Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Dengue Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Dengue Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Dengue Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Dengue Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Dengue Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Dengue Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Dengue Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Dengue Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Dengue Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Dengue Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Dengue Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Dengue Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Dengue Vaccine Consumption Forecast by Country (2022-2028)

    • Figure China Dengue Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Dengue Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Dengue Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Dengue Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Dengue Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Dengue Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Dengue Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Dengue Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Dengue Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Dengue Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Dengue Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Dengue Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Dengue Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Brazil Dengue Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Dengue Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Dengue Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Dengue Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Dengue Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Dengue Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Dengue Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Dengue Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Dengue Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Dengue Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Dengue Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Dengue Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Dengue Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Dengue Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Dengue Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Dengue Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Dengue Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Dengue Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Dengue Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Dengue Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Dengue Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Australia Dengue Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Dengue Vaccine Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US